D. E. Shaw & Co., Inc. Neuronetics, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.09 - $3.71 $100,656 - $178,677	-48,161 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.84 - $4.52 $136,777 - $217,687	48,161 New	48,161 $146,000
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $101,796 - $254,327	-16,366 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $166,114 - $282,313	16,366 New	16,366 $262,000

13M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $63.2M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.